Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.

Share:
More In Business
Stretching Your Dollar: How to Eliminate and Manage Debt
With the New Year around the corner, it's time to start thinking about resolutions. Many folks begin to think about saving money or cutting down on bills. Caleb Silver, editor-in-chief of Investopedia, joined Cheddar News to provide some tips on tracking debt and staying organized.
Load More